Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors. Objectives This cross‐sectional study described and eva...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg
Format:	Artigo
Jezik:	Inglês
Izdano:	Wiley 2026-03-01
Serija:	JEADV Clinical Practice
Teme:	atopic dermatitis biologics JAK inhibitors real‐world evidence
Online dostop:	https://doi.org/10.1002/jvc2.70153
Oznake:	Označite Brez oznak, prvi označite!